SRRK SRRK

Scholar Rock Stock Price

5.42
0.00 (0.0%)
5.42
Volume 0
Bid Price 5.00
Ask Price 6.29
News -
Day High

Low
4.325

52 Week Range

High
44.95

Day Low
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Scholar Rock Holdings Corporation SRRK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 5.42 04:00:00
Open Price Low Price High Price Close Price Prev Close
5.42
Trades Volume Avg Volume 52 Week Range
0 0 - 4.325 - 44.95
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 5.42 USD

Period:

Draw Mode:

Scholar Rock Holdings Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 279.82M 51.63M 34.70M $ 18.82M $ - -3.59 -1.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 196.00k 10.70%

more financials information »

Scholar Rock News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SRRK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.358.055.136.382,581,4710.071.31%
1 Month4.738.784.3255.573,022,8330.6914.59%
3 Months13.9914.304.3255.951,401,781-8.57-61.26%
6 Months25.9126.574.3257.86788,323-20.49-79.08%
1 Year28.5044.954.32512.93497,756-23.08-80.98%
3 Years15.9370.004.32526.27435,318-10.51-65.98%
5 Years14.2570.004.32525.75345,603-8.83-61.96%

Scholar Rock Description

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is SRK-015 which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle.


Your Recent History
NASDAQ
SRRK
Scholar Ro..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.